NPR logo

More Drugs to Fight Diabetes Are On the Way

  • Download
  • <iframe src="https://www.npr.org/player/embed/11181146/11181147" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
More Drugs to Fight Diabetes Are On the Way

Health Care

More Drugs to Fight Diabetes Are On the Way

More Drugs to Fight Diabetes Are On the Way

  • Download
  • <iframe src="https://www.npr.org/player/embed/11181146/11181147" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

In 2005, Americans spent almost $10 billion on diabetes drugs — and that is supposed to increase over the next two years. Later this week in Chicago, drug companies will release new diabetes drugs they hope will fuel the spending surge.

STEVE INSKEEP, host:

NPR's Business News starts with the high cost of treating diabetes.

A new study shows one out of every eight federal health care dollars is spent treating people with diabetes. In 2005, Americans spend almost $10 billion on diabetes drugs. And that's big business. It is supposed to increase over the next two years.

Later this week in Chicago, drug companies will release new diabetes drugs that they hope will fuel the spending surge. Older diabetes drugs, Avandia and Actos, have come under fire for potentially raising the risk of heart attacks.

Copyright © 2007 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.